LEVETIRACETAM
ANTICONVULSANTS · MYOCLONIC EPILEPSY ADJUNCT TREATMENT ·+2
PRASCO LABS
Drug class
Anticonvulsant - Pyrrolidine Derivatives
Anticonvulsant pyrrolidine derivatives are a chemically defined therapeutic class of antiseizure medications, characterized by a central pyrrolidine or 2-oxopyrrolidine ring structure, exemplified by agents such as levetiracetam and brivaracetam. Read more about Anticonvulsant - Pyrrolidine Derivatives
116 drugs in this class 85 manufacturers
Drugs in Anticonvulsant - Pyrrolidine Derivatives
LEVETIRACETAM
ANTICONVULSANTS · MYOCLONIC EPILEPSY ADJUNCT TREATMENT ·+2
ASCEND LABORATO
LEVETIRACETAM
ANTICONVULSANTS · MYOCLONIC EPILEPSY ADJUNCT TREATMENT ·+2
PRECISION DOSE
LEVETIRACETAM ER (levetiracetam)
ANTICONVULSANTS · FOCAL EPILEPSY
WESTMINSTER PHA
LEVETIRACETAM
ANTICONVULSANTS · MYOCLONIC EPILEPSY ADJUNCT TREATMENT ·+2
BIONPHARMA INC.
LEVETIRACETAM
ANTICONVULSANTS · MYOCLONIC EPILEPSY ADJUNCT TREATMENT ·+2
ACI HEALTHCARE
LEVETIRACETAM
ANTICONVULSANTS · MYOCLONIC EPILEPSY ADJUNCT TREATMENT ·+2
EYWA PHARMA INC
LEVETIRACETAM
ANTICONVULSANTS · MYOCLONIC EPILEPSY ADJUNCT TREATMENT ·+2
NOVADOZ PHARMAC
LEVETIRACETAM
ANTICONVULSANTS · MYOCLONIC EPILEPSY ADJUNCT TREATMENT ·+2
ARMAS PHARMACEU
Filter & compare in the drug finder →
Opens the drug finder with Anticonvulsant - Pyrrolidine Derivatives preselected. Add indication or manufacturer filters there.
Anticonvulsant pyrrolidine derivatives are a chemically defined therapeutic class of antiseizure medications, characterized by a central pyrrolidine or 2-oxopyrrolidine ring structure, exemplified by agents such as levetiracetam and brivaracetam.
Their primary mechanism of action involves high-affinity binding to synaptic vesicle protein 2A (SV2A) in the central nervous system, which modulates presynaptic vesicle exocytosis and reduces excessive, synchronized neurotransmitter release.
Clinically, these agents are utilized for the management of epilepsy disorders, serving as monotherapy or adjunctive therapy for partial-onset (focal) seizures as well as generalized tonic-clonic and myoclonic seizures.
-
google.com
Anticonvulsant pyrrolidine derivatives are a chemically defined therapeutic class of antiseizure medications, characterized by a central pyrrolidine or 2-oxopyrrolidine ring structure, exemplified by agents such as levetiracetam and brivaracetam Clinically, these agents are utilized for the management of epilepsy disorders, serving as monotherapy or adjunctive therapy for partial-onset (focal) seizures as well as generalized tonic-clonic and myoclonic seizures
-
paragraphfour.com
Anticonvulsant pyrrolidine derivatives are a chemically defined therapeutic class of antiseizure medications, characterized by a central pyrrolidine or 2-oxopyrrolidine ring structure, exemplified by agents such as levetiracetam and brivaracetam
-
nih.gov
Anticonvulsant pyrrolidine derivatives are a chemically defined therapeutic class of antiseizure medications, characterized by a central pyrrolidine or 2-oxopyrrolidine ring structure, exemplified by agents such as levetiracetam and brivaracetam Their primary mechanism of action involves high-affinity binding to synaptic vesicle protein 2A (SV2A) in the central nervous system, which modulates presynaptic vesicle exocytosis and reduces excessive, synchronized neurotransmitter release Clinically, ...
-
nih.gov
Their primary mechanism of action involves high-affinity binding to synaptic vesicle protein 2A (SV2A) in the central nervous system, which modulates presynaptic vesicle exocytosis and reduces excessive, synchronized neurotransmitter release
-
nih.gov
Their primary mechanism of action involves high-affinity binding to synaptic vesicle protein 2A (SV2A) in the central nervous system, which modulates presynaptic vesicle exocytosis and reduces excessive, synchronized neurotransmitter release
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.